Radiofrequency Chip for Localization of Non-Palpable Breast Lesions

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

April 19, 2021

Study Completion Date

April 19, 2021

Conditions
Breast Tumor
Interventions
DEVICE

RFID Localization

The RFID and wire localization devices used in this study are FDA approved for the image guided localization of breast tumors prior to surgical excision. The two techniques for localization will be compared in this trial.

DEVICE

Wire Localization

The RFID and wire localization devices used in this study are FDA approved for the image guided localization of breast tumors prior to surgical excision. The two techniques for localization will be compared in this trial.

DEVICE

RFID and Wire Localization

Both RFID and the standard of care wire localization will be performed for physician training.

Trial Locations (1)

65212

University of Missouri, Columbia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Health Beacons

INDUSTRY

lead

University of Missouri-Columbia

OTHER